SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-009961
Filing Date
2019-11-05
Accepted
2019-11-05 16:01:45
Documents
74
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vvus-20190930x10q.htm 10-Q 2610173
2 EX-31.1 vvus-20190930ex3113e687c.htm EX-31.1 19939
3 EX-31.2 vvus-20190930ex312f3fdd9.htm EX-31.2 19577
4 EX-32 vvus-20190930xex32.htm EX-32 16835
  Complete submission text file 0001558370-19-009961.txt   8674617

Data Files

Seq Description Document Type Size
5 EX-101.INS vvus-20190930.xml EX-101.INS 1942317
6 EX-101.SCH vvus-20190930.xsd EX-101.SCH 44397
7 EX-101.CAL vvus-20190930_cal.xml EX-101.CAL 75740
8 EX-101.DEF vvus-20190930_def.xml EX-101.DEF 173980
9 EX-101.LAB vvus-20190930_lab.xml EX-101.LAB 425372
10 EX-101.PRE vvus-20190930_pre.xml EX-101.PRE 346948
Mailing Address 900 E. HAMILTON AVENUE SUITE 550 CAMPBELL CA 95008
Business Address 900 E. HAMILTON AVENUE SUITE 550 CAMPBELL CA 95008 6509345200
VIVUS INC (Filer) CIK: 0000881524 (see all company filings)

IRS No.: 943136179 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33389 | Film No.: 191193208
SIC: 2834 Pharmaceutical Preparations